Wenyuan Mai
机构:First Affiliated Hospital Zhejiang University, Zhejiang University
发表论文 78 篇 · 总被引 850 次 · h-index 17
代表论文
- Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial (2022 · The Lancet Haematology · 被引 113)
- Rituximab, lenalidomide and BTK inhibitor as frontline treatment for elderly or unfit patients with diffuse large B-cell lymphoma: a real-world analysis of single center (2022 · Experimental Hematology and Oncology · 被引 21)
- A real-world study of infectious complications of venetoclax combined with decitabine or azacitidine in adult acute myeloid leukemia (2022 · Supportive Care in Cancer · 被引 17)
- The clinical impact of IKZF1 mutation in acute myeloid leukemia (2023 · Experimental Hematology and Oncology · 被引 16)
- Dasatinib plus prednisone as induction and consolidation for adults with Ph‐positive acute lymphoblastic leukaemia: A single‐arm, multicentre, phase 2 trial (2023 · British Journal of Haematology · 被引 10)
- New insights into the clinical characteristics of SETD2 ‐mutated acute myeloid leukaemia (2023 · British Journal of Haematology · 被引 6)